Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Decreased IGF-1R expression may contribute to sacrococcygeal pilonidal sinus development.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Eating high-glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Clascoterone may be an effective topical treatment for hair loss.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Cattle skin has leptin which might control skin and hair growth.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Lespedeza cuneata extract may help treat enlarged prostate.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Sandalore® improves hair growth and quality in people with hair loss.